SCHEMBL1027939

SCHEMBL1027939

CCCCCCCCCCCCCCC(=NNC(=S)N(C)C)C(c1ccccn1)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.41
▸ HTT P42858 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ KDM4E B2RXH2 4/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TSHR P16473 1/20 0.37
▸ KCNA5 P22460 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ KCNE1 P15382 1/20 0.34
▸ FAAH O00519 2/20 0.34
▸ CES1 P23141 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1027788 0.86 LMNA (0.43) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1027263 0.85 TOP2A (0.46) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1028980 0.84 TOP2A (0.51) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1029009 0.83 LMNA (0.40) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1026244 0.80 ALDH1A1 (0.53) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1025805 0.80 SMN1; SMN2 (0.46) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1026536 0.78 NAAA (0.45) LMNAHTTSMN1; SMN2CYP1A2CYP2C19
SCHEMBL3966650 0.78 LMNA (0.56) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1027198 0.78 MAPT (0.45) LMNAHTTSMN1; SMN2KDM4ECYP1A2
SCHEMBL1025204 0.77 MAPT (0.47) LMNAHTTSMN1; SMN2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2453892-B1 PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATING CANCER INST NAT SANTE RECH MED (FR) 2013-05-29 — — EP claimed
EP-1608623-B1 METAL ION CHELATORS AND THERAPEUTIC USE THEREOF RICHARDSON DESI RAYMOND (AU) 2011-01-19 — — EP claimed
Send feedback